IPR

To stimulate the development of new medicines, various forms of ‘supplementary protections’ exist that give companies extended monopoly rights. This includes: Supplementary Protection Certificates (SPCs), which prolong the patent protection for medicinal products by up to five years; paediatric extensions to SPCs; regulatory protection in the form of data and market exclusivity; as well as…

The study aims to provide “Support for an ex-post evaluation of Directive 2004/48/EC [IPRED] and for an Impact Assessment in view of legislative proposals modernising the enforcement of IPR”. IPRED has been implemented between 2005-2009. A first, early evaluation (2011) could not establish significant impacts. Given the changes – in particular in the digital environment…

Open Innovation (OI) is a new paradigm for collaborative innovation projects. With the advent of advanced internet technologies there are novel technological opportunities to create web-based platforms that facilitate such collaboration – e.g., crowd-sourcing platforms, ideation platforms or platforms that help find partners for the commercialisation of IP. The German Federal Ministry for Economic Affairs…

The report sets out the key findings and recommendations from a study into intellectual property activity, intellectual property strategies, and barriers to engaging in intellectual property for firms in Ireland, and will serve as a key input for the development of a new national Strategy for Science, Technology and Innovation.

This study was an impact assessment of utility model legislation in Europe. In particular, it included an analysis of how this type of patent-like IPR instrument supports incremental innovation. It also scrutinised usage of utility models (motives, barriers) in Europe. We drafted recommendations for the EU and the EC on how to further deal with the…

Every year, the European Patent Office (EPO)  awards inventions with proven economic and societal impacts in the categories ‘industry’, ‘SMEs’, ‘research/universities’, ‘non-European countries’ and ‘lifetime achievement’. Technopolis has been, since 2011, repeatedly contracted by the EPO to perform background analyses and valuations of the impacts of patents and inventions nominated for the European Inventor Award  (EIA)….

The European Commision asked Technopolis to identify optimal effectiveness of Science, Technology and Innovation Agreements with non-EU countries. We showed that many bilateral STI agreements signed by EU Member States are of limited use. However, as both the EU and Member States seek to treat scientific cooperation with third countries as an issue of common…

As part of a consortium with Bocconi University and KU Leuven, Technopolis studied, on behalf of the European Commission, DG Research and Innovation, the patent/technology out- and in-licensing behaviour of European firms. To this end, Technopolis launched the largest and most detailed survey on patentees in Europe to date. Based on responses of 330 patent-holding…